EOCNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Galmed Pharmaceuticals Ltd.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 31, 2026
$2.85−0.00 (-0.00%)
Close on Oct 19, 2026
- Market cap
- $2.71M
- P/E (TTM)
- 0.1
- Dividend yield
- –
Price history
Daily open, high, low, close and volume
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Daily prices are not in StockData yet. This table fills in once an end-of-day price source is connected. | ||||||
Stock splits
From SEC filings
| Date | Ratio | Effect on per-share figures |
|---|---|---|
| Sep 2, 2026(first seen in filings) | 1-for-8 reverse | Earlier per-share figures multiplied by 8 |
| Aug 19, 2026 | 1-for-8 reverse | Earlier per-share figures multiplied by 8 |
| Apr 2, 2025(first seen in filings) | 1-for-12 reverse | Earlier per-share figures multiplied by 12 |
| Aug 30, 2024 | 1-for-12 reverse | Earlier per-share figures multiplied by 12 |
| Aug 9, 2023(first seen in filings) | 1-for-15 reverse | Earlier per-share figures multiplied by 15 |
| May 15, 2023 | 1-for-15 reverse | Earlier per-share figures multiplied by 15 |